The Spanish scientific milestone against ticks that will transform the livestock industry

게시됨 2024년 12월 2일

Tridge 요약

A team of Spanish researchers has developed a revolutionary vaccine against cattle ticks in collaboration with Uganda's National Agricultural Research Organisation (NARO). The vaccine, named NAROVAC ATV-1, has been approved by the Uganda National Council for Science and Technology and is expected to produce 30 million doses annually. The vaccine, which has an efficacy of 98.8%, not only protects cattle from tick-borne diseases but also has the potential to reduce tick populations through the transfer of antibodies from the vaccinated animals to the ticks, thereby breaking the disease transmission cycle. This development is set to revolutionize livestock farming in sub-Saharan Africa, where tick-borne diseases significantly impact the industry.

면책 조항: 위의 요약은 정보 제공 목적으로 Tridge 자체 학습 AI 모델에 의해 생성되었습니다.

원본 콘텐츠

Ticks only make the news in Spain from time to time, for example, if a fatal case of Crimean-Congo haemorrhagic fever appears. Although it is becoming more frequent, in our area it is still exceptional. However, the bite of these parasites, which feed on blood and transmit this and many other diseases to people and animals, is a daily drama in some areas of the world, especially countries where life and economy revolve around livestock. A group of Spanish researchers has worked for almost a decade to change this situation and the result promises to have a spectacular international impact. Uganda is beginning to produce the first doses of a new vaccine against cattle ticks that is the result of the efforts of José de la Fuente, Marinela Contreras and Christian Gortázar, scientists from the Health and Biotechnology Group (SaBio) of the Institute for Research in Game Resources (IREC, a centre of the CSIC, the University of Castilla-La Mancha and the Regional Government of Castilla-La ...

출처: Agromeat